Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Afatinib After Progression on Osimertinib in Patients with EGFR-Mutated Lung Adenocarcinoma Aredo, J., Wakelee, H. A., Neal, J., Padda, S. ELSEVIER SCIENCE INC. 2021: S619
View details for Web of Science ID 000631349601545